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1. INTRODUCTION {#brb31658-sec-0006}
===============

Craniotomy, as a neurosurgical procedure, has been performed more than a century and is characterized by performing within the intracranial space (Adaaquah, Gates, & Van Gompel, [2018](#brb31658-bib-0002){ref-type="ref"}; Gonzalez‐Darder, [2016](#brb31658-bib-0015){ref-type="ref"}). Intracranial infections, including brain abscess, meningitis, and subdural or epidural infections, are serious complications after craniotomy (Horan, Andrus, & Dudeck, [2008](#brb31658-bib-0017){ref-type="ref"}). Intracranial infection poses significant problems for patients\' outcomes (Kourbeti, Jacobs, Koslow, Karabetsos, & Holzman, [2007](#brb31658-bib-0023){ref-type="ref"}; National Nosocomial Infections Surveillance System, [2004](#brb31658-bib-0029){ref-type="ref"}), and it may cause high rate of morbidity and mortality, prolonged length of stay, extra healthcare cost, and multiple surgeries (Hweidi, Barbarawi, Tawalbeh, Al‐Hassan, & Al‐Ibraheem, [2018](#brb31658-bib-0019){ref-type="ref"}; Korinek, [1997](#brb31658-bib-0022){ref-type="ref"}; Rebuck, Murry, Rhoney, Michael, & Coplin, [2000](#brb31658-bib-0030){ref-type="ref"}).

White blood cell count or neutrophil count is still indicators of infection and clinical judgment; however, their specificity might not be high (Folyovich et al., [2014](#brb31658-bib-0013){ref-type="ref"}; Westendorp, Nederkoorn, Vermeij, Dijkgraaf, & van de Beek, [2011](#brb31658-bib-0033){ref-type="ref"}). Surgical drainage and antibiotics are also the effective therapy to treat intracranial infection (Dashti et al., [2008](#brb31658-bib-0009){ref-type="ref"}; Kural et al., [2019](#brb31658-bib-0025){ref-type="ref"}). However, many drugs are facing difficulty to penetrate into brain due to the blood--brain barrier (BBB) (Daneman & Prat, [2015](#brb31658-bib-0008){ref-type="ref"}). Meanwhile, cerebrospinal fluid (CSF) only can be drained a little through lumbar puncture. Therefore, it is of great significance to explore risk factors for intracranial infection after craniotomy in order to timely prevent it.

Currently, more than 10 high‐risk factors have been reported, which were mainly for surgical site infection after craniotomy (Adaaquah et al., [2018](#brb31658-bib-0002){ref-type="ref"}; Fang, Zhu, Zhang, Xia, & Sun, [2017](#brb31658-bib-0011){ref-type="ref"}; Kourbeti et al., [2007](#brb31658-bib-0023){ref-type="ref"}). However, the risk factors of season and postoperative oral infection were not analyzed. In the 1982s, the seasonal variation in arterial blood pressure was reported (Brennan, Greenberg, Miall, & Thompson, [1982](#brb31658-bib-0004){ref-type="ref"}). In addition, Herweh et al have concluded that hypertensive intracerebral hemorrhage was associated with the increased air pressure by conducting a worldwide cohort (Herweh et al., [2017](#brb31658-bib-0016){ref-type="ref"}). As regards the oral infection, one previous study has reported that brain abscesses might be the potential deadly complications of odontogenic infections through summarizing related cases (Moazzam, Rajagopal, Sedghizadeh, Zada, & Habibian, [2015](#brb31658-bib-0027){ref-type="ref"}). However, there was no case--control study performed to verify the relationship between oral infection and intracranial infection.

In our study, we calculated the prevalence of intracranial infection after craniotomy and further identified the risk factors for intracranial infection, especially some new risk factors such as surgical season and postoperative oral infection. Furthermore, microorganisms and its antibiotic resistance isolated from cerebrospinal fluid (CSF) were also determined.

2. PARTICIPANTS AND METHODS {#brb31658-sec-0007}
===========================

2.1. Participants {#brb31658-sec-0008}
-----------------

The enrolled patients were admitted from Department of Neurosurgery in the Second Hospital of Hebei Medical University between 1 May 2018 and 30 June 2019. Written informed consent was obtained from all individual participants. This study was approved by the Research Ethics Committee of the Second Hospital of Hebei Medical University (No. 2018‐R084). Patients who underwent craniotomy were included. Patients were excluded if they: (a) did not receive craniotomy; (b) were accompanied by severe organ functional lesion, malignant tumor, metabolic diseases, blood systemic diseases, and spinal deformity; (c) gave up treatment; (d) were too fat to perform lumbar puncture; (e) had failed lumbar puncture; (f) were treated by nonsurgical treatment, such as intravenous antibiotics; and (g) had adhesion of subarachnoid space to cerebrospinal fluid circulation disorder.

2.2. Study design {#brb31658-sec-0009}
-----------------

This retrospective case--control study was performed according to clinical test procedures of National Health and Family Planning Commission of the People\'s Republic of China. A total of 2,174 consecutive patients who underwent craniotomy were enrolled. Intracranial infection was determined by two brain surgery experts based on the indicators of the cases and the results of biochemical microorganisms. If the two experts got different decisions, the third expert would control quality by interpreting the results. At the same time, patients in the case groups were identified to have consecutive intracranial infections during hospitalization. Among the 2,174 patients, 201 patients were infected with intracranial infection after craniotomy, but five patients were excluded for having intracranial infection after 30 June 2019. Therefore, the 196 patients with intracranial infections were classified as case group. The data collection was difficult due to the poor condition of our hospital, and 392 cases in the control group, twice as many as in the case group, were randomly selected from the remaining 1,973 patients without intracranial infection. Case and control groups chose the same consecutive patients who underwent craniotomy. The flow diagram is shown in Figure [1](#brb31658-fig-0001){ref-type="fig"}. The prevalence of nosocomial intracranial infection was defined to be happened after 48 hr of admission to control the prevalence--incidence bias. In addition, the blind method was used to control the investigation bias, all patients or clinicians did not know the information to distinguish the case group from the control group.

![Flow diagram of patient selection](BRB3-10-e01658-g001){#brb31658-fig-0001}

2.3. Definitions {#brb31658-sec-0010}
----------------

Intracranial infection was diagnosed according to the definitions of Centers for Disease Control (CDC) (Horan et al., [2008](#brb31658-bib-0017){ref-type="ref"}). The prevalence of intracranial infection was defined to be happened: (a) after 48 hr of admission; (b) during operation or pathological examination; (c) from organisms cultured from brain tissue or dura; (d) considering at least the following two signs such as dizziness, fever (\>38°C), headache, local neurosis, consciousness‐changing, or confusion; (e) and from (a) microorganisms identified from brain tissue, abscess tissue, blood, or urine; (b) diagnostic single‐antibody titer (IgM) or fourfold increase in paired sera (IgG) for pathogen; and (c) radiographic evidence of infection.

The surgical seasons were divided into four according to the 24 solar terms of China. Spring was from 15 April to 20 June in 2018 and 21 March to 15 April in 2019. Summer was defined from 21 June to 22 September in 2018. Autumn was from 23 September to 6 November in 2018. Winter was defined from 7 November in 2018 to 20 March in 2019.

Cerebrospinal fluid leak was defined as any leak of the fluid that surrounds the brain and spinal cord and escapes from the cavities within the brain or central canal in the spinal cord (Abuabara, [2007](#brb31658-bib-0001){ref-type="ref"}), and was reported to be associated with the development of meningitis (Jones & Becker, [2001](#brb31658-bib-0021){ref-type="ref"}).

2.4. Data collection {#brb31658-sec-0011}
--------------------

The demographic, clinical, laboratory, microbiological, and antimicrobial data were systemically analyzed by same team, laboratory and healthcare department. The clinical data were further analyzed by reviewing electronic medical records and files. The other data were collected from three electronic surveillance systems: Nosocomial infection records were from the Ongoing Nosocomial Infection Surveillance of Xinglin; clinical data were from electronic medical records; and microbiological and antimicrobial data were from microbial systems.

The detailed demographic, clinical, and laboratory factors were as follows: Preoperative factors included hospital length of stay (LOS), emergency (patients with serious condition or suffering from car accident), and other surgeries (surgery with posterior fossa, bilateral surgery, and external CSF drainage); intraoperative factors included surgical season, surgical duration, and intraoperative blood loss; and postoperative factors included signs of oral infection, cerebral hernia, acid inhibitors, reoperation, CSF leak, coma, intensive nursing care, American Society of Anesthesiologists (ASA) score, albumin level (ALB), high‐sensitivity C‐reactive protein (hsCRP) level, red blood cell count (RBC) level, and serum hemoglobin (HGB) level. The normal values of postoperative indexes of ALB, hsCRP, RBC, and serum HGB were 40--55 g/L, 0--6 mg/L, 4.3--5.8 × 10^12^ L (men) and 3.8--5.10 × 10^12^ L (women), and 130--175 g/L (men) and 115--150 g/L (women), respectively. In addition, gender, age, hypertension, hyperlipidemia, diabetes mellitus, trauma, and tumor were also included.

2.5. Determination of the cut‐point of quantitative variables {#brb31658-sec-0012}
-------------------------------------------------------------

As shown in Table [1](#brb31658-tbl-0001){ref-type="table"}, the average age of the targeted population was 48.87 ± 16.21 years. The age of 45 years was selected as cut‐point. The average surgical duration and preoperative LOS were 4.62 ± 2.03 hr and 7.44 ± 6.56 days, 4 hr and 7 days were selected as cut‐points, respectively. The ASA score ranges from 1 to 5 (Saklad, [1941](#brb31658-bib-0031){ref-type="ref"}). The mean ASA score in the case and control group was 2.49 ± 0.89 and 2.51 ± 0.85, respectively, a score of 2 was selected as cut‐points. Due to intraoperative blood loss, at least 400 ml was considered as a major bleeding in clinical diagnosis, 400 ml was selected as cut‐points.

###### 

Baseline characteristics of the case group and the control group

  Variable                                           Targeted population (*n* = 588)   Case group (*n* = 196)    Control group (*n* = 392)   *p* (case vs. control)
  -------------------------------------------------- --------------------------------- ------------------------- --------------------------- ------------------------
  Age (years, mean \[*SD*\])                         48.87 ± 16.21                     47.08 ± 17.10             49.76 ± 15.69               .092
  Gender (men, *n* \[%\])                            290 (49.32)                       109 (55.61%)              181 (46.17%)                .031
  Surgical duration (hr, mean \[*SD*\])              4.62 ± 2.03                       5.46 ± 2.27               4.19 ± 1.75                 .439
  Preoperative LOS (days, mean \[*SD*\])             7.44 ± 6.56                       7.76 ± 6.90               7.28 ± 6.39                 .404
  LOS (days, mean \[*SD*\])                          27.08 ± 16.95                     35.45 ± 21.14             22.89 ± 12.49               \<.001
  Intraoperative blood loss (ml, median \[IQR\])     200.00 (100.00 -- 400.00)         300.00 (150.00, 475.00)   200.00 (100.00, 300.00)     \<.001
  Postoperative ASA score                            2.50 ± 0.86                       2.49 ± 0.89               2.51 ± 0.85                 .731
  Hypertension (%)                                   243 (41.33)                       93 (47.45)                150 (38.26)                 .033
  Hyperlipidemia (%)                                 3 (0.51)                          0 (0.00)                  3 (0.77)                    .219
  Diabetes mellitus (%)                              59 (10.03)                        21 (10.71)                38 (9.69)                   .698
  Trauma surgery (%)                                 81 (13.78)                        7 (3.57)                  74 (18.88)                  \<.001
  Tumor surgery (%)                                  185 (31.46)                       91 (46.43)                94 (23.98)                  \<.001
  Postoperative serum RBC (1,012 L, mean \[*SD*\])   4.27 ± 4.23                       3.99 (3.60, 4.31)         3.97 ± 0.58                 .162
  Postoperative serum HGB (g/L, mean \[*SD*\])       118.98 ± 19.98                    120.03 ± 23.84            118.45 ± 17.75              .136
  Postoperative serum hsCRP (mg/L, median \[IQR\])   13.250 (6.500 -- 32.52)           13.40 (6.10, 30.36)       11.80 (6.68, 37.10)         .376
  Postoperative serum ALB (g/L, mean \[*SD*\])       38.166 ± 16.207                   39.42 ± 16.00             37.54 ± 16.30               .186

Abbreviations: ALB, albumin; ASA, American Society of Anesthesiologists; HGB, hemoglobin; hsCRP, high‐sensitivity C‐reactive protein; IQR, interquartile range; LOS, length of stay; RBC, red blood cell count; *SD*, standard deviation.
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2.6. The clinical diagnostic routine of microbiology methods {#brb31658-sec-0013}
------------------------------------------------------------

If patients in the case group were with the symptoms of headaches, fever, nausea, and vomiting, 3--5 ml CSF was collected from brain or abscess tissue by needle aspiration or biopsy during surgical operation or autopsy, and stored in sterile test tubes for detecting the infection within 1 hr. The microorganisms were cultured in the Vitek compact autokinetic microbe culture instrument (bioMerieux).

2.7. The clinical diagnostic routine of antimicrobial susceptibility testing {#brb31658-sec-0014}
----------------------------------------------------------------------------

Antimicrobial susceptibility test was implemented through computer‐assisted microbiology laboratory database. Thirty‐four antimicrobial agents were tested including aztreonam, cefazolin, benzylpenicillin, cefuroxime, penicillin, ampicillin, ampicillin/sulbactam, ceftriaxone, erythromycin, biapenem, cefotetan, cefepime, piperacillin, cefoxitin, clindamycin, meropenem, imipenem, ceftazidime, tobramycin, piperacillin/tazobactam, ciprofloxacin, levofloxacin, cefoperazone/sulbactam, polymyxin B, tetracycline, gentamicin, moxifloxacin, amikacin, nitrofurantoin, rifampicin, vancomycin, tigecycline, linezolid and minocycline. Polymyxin was performed by the broth dilution method to determine the minimum inhibitory concentrations (MICs), while others were determined by the agar dilution method (Wiegand, Hilpert, & Hancock, [2008](#brb31658-bib-0034){ref-type="ref"}). The quality control strains were *Escherichia coli* ATCC 25922, *Pseudomonas aeruginosa* ATCC 27853, *Staphylococcus aureus* ATCC 29213, and *Enterococcus faecalis* ATCC 29212. The sensitive or intermediary strains were defined as nonresistant strains in the antimicrobial susceptibility testing. All results of antimicrobial susceptibility test were interpreted according to the updated standards recommended by Clinical and Laboratory Standard Institution (CLSI) and analyzed by Whonet 5.6 software (Hsueh et al., [2010](#brb31658-bib-0018){ref-type="ref"}; Nakamura et al., [2007](#brb31658-bib-0028){ref-type="ref"}).

2.8. Statistical analysis {#brb31658-sec-0015}
-------------------------

Statistical analyses were performed using SPSS Statistics version 22.0 (IBM Corporation). Controls were randomly selected from patients without intracranial infection after craniotomy by SPSS Statistics version 22.0. The proportion of the case group versus control group was 1:2. Categorical variables were presented as frequencies and percentages. Normally and non‐normally distributed continuous variables were given as means ± standard deviation (*SD*) and median (interquartile range, IQR). Comparisons of continuous variables were performed using two‐sided *t* test for normally distributed variables or the chi‐square test for dichotomous variables. As for non‐normally distributed continuous variables, we used Wilcoxon rank sum test. The chi‐square test was used to screen potential risk factors, and independent risk factors for intracranial infection were determined based on binary logistic regression analysis. Intracranial infection was employed as dependent variable in logistic regression model to adjusting the confounder. Variables with *p* value \< .10 tested by univariate analysis were enrolled in binary logistic regression analysis. For all statistical data in binary logistic regression analysis, variables with *p* \< .05 were significant. EpiData 3.1 was used to input these data by two graduate students. We have another staff to verify these data.

3. RESULT {#brb31658-sec-0016}
=========

3.1. Comparisons of demographics between the case group and the control group {#brb31658-sec-0017}
-----------------------------------------------------------------------------

The analysis included 588 patients, 196 cases in the case group and 392 cases in the control group. Men accounted for 49.32% of all patients. As shown in Table [S1](#brb31658-sup-00001){ref-type="supplementary-material"}, the baseline between every kind of missing value group and nonmissing value group was comparable, with *p* value above .05. Then, the expectation--maximization (EM) in missing value analysis of SPSS 22.0 was used to replace missing values with an estimation. The *p* value of Little\'s MCAR test was .000, so the missing values were missing at random (MAR). The baseline characteristics of the case group and control group are summarized in Table [1](#brb31658-tbl-0001){ref-type="table"}. There was no significant difference in terms of age (47.08 ± 17.10 vs. 49.76 ± 15.69, *p* = .092), surgical duration (5.46 ± 2.27 vs. 4.19 ± 1.75, *p* = .439), preoperative LOS (7.76 ± 6.90 vs. 7.28 ± 6.39, *p* = .404), ASA score (2.49 ± 0.89 vs. 2.51 ± 0.85, *p* = .731), hyperlipidemia (0.00% vs. 0.77%, *p* = .219), diabetes mellitus (10.71% vs. 9.69%, *p* = .698), postoperative serum RBC \[3.99 (3.60, 4.31) vs. (3.97 ± 0.58), *p* = .162\], postoperative serum HGB (120.03 ± 23.84 vs. 118.45 ± 17.75, *p* = .136), postoperative serum hsCRP \[13.40 (6.10, 30.36) vs. 11.80 (6.68, 37.10), *p* = .376\], and postoperative serum ALB (39.42 ± 16.00 vs. 37.54 ± 16.30, *p* = .186) between the case group and the control group. However, there were significant differences in terms of gender (male, 55.61% vs. 46.17%, *p* = .031), LOS (35.45 ± 21.14 vs. 22.89 ± 12.49, *p* \< .001), intraoperative blood loss \[300.00 (150.00, 475.00) vs. 200.00 (100.00, 300.00), *p* \< .001\], hypertension (47.45% vs. 38.26%, *p* = .033), trauma surgery (3.57% vs. 18.88%, *p* \< .001), and tumor surgery (46.43% vs. 23.98%, *p* \< .001) between the case group and the control group.

3.2. Univariate analysis of potential risk factors {#brb31658-sec-0018}
--------------------------------------------------

The potential risk factors are shown in Table [2](#brb31658-tbl-0002){ref-type="table"}. Men were more likely to have intracranial infection after craniotomy compared with women (*p* \< .1). Age ≤ 45, hypertension, nontrauma surgery, and tumor surgery were significantly associated with an increased risk of intracranial infection (*p* \< .1). Hyperlipidemia and diabetes mellitus were not the potential risk factors related to intracranial infection (*p* \> .1).

###### 

Univariate analysis of potential risk factors for intracranial infection after craniotomy

  Variable (%)                           Assigned      Case group (*n* = 196)   Control group (*n* = 392)   *χ* ^2^   *p*      OR      95% CI
  -------------------------------------- ------------- ------------------------ --------------------------- --------- -------- ------- ---------------
  Gender                                 Female        87 (44.39)               211 (53.83)                 4.657     .031     1.461   1.035--2.062
  Male                                   109 (55.61)   181 (46.17)                                                                     
  Age                                    \>45          117 (59.69)              281 (71.68)                 8.588     .003     1.709   1.192--2.450
  ≤45                                    79 (40.31)    111 (28.32)                                                                     
  Hypertension                           No            103 (52.55)              242 (61.73)                 4.545     .033     1.457   1.030--2.060
  Yes                                    93 (47.45)    150 (38.26)                                                                     
  Hyperlipidemia                         No            196 (100.00)             389 (99.23)                 1.508     .219     0.665   0.628--0.704
  Yes                                    0 (0.00)      3 (0.77)                                                                        
  Diabetes mellitus                      No            175 (89.29)              354 (90.31)                 0.151     .698     1.118   0.637--1.963
  Yes                                    21 (10.71)    38 (9.69)                                                                       
  Trauma surgery                         No            189 (96.43)              318 (81.12)                 25.773    \<.001   0.159   0.072--0.353
  Yes                                    7 (3.57)      74 (18.88)                                                                      
  Tumor surgery                          No            105 (53.57)              298 (76.02)                 30.538    \<.001   2.748   1.909--3.954
  Yes                                    91 (46.43)    94 (23.98)                                                                      
  Preoperative LOS (days)                \<7           94 (47.96)               193 (49.23)                 0.085     .771     1.052   0.747--1.483
  ≥7                                     102 (52.04)   199 (50.77)                                                                     
  Emergency                              No            138 (70.41)              274 (69.90)                 0.016     .899     0.976   0.671--1.420
  Yes                                    58 (29.59)    118 (30.10)                                                                     
  Surgery with posterior fossa           No            164 (83.67)              356 (90.82)                 6.519     .011     1.930   1.158--3.216
  Yes                                    32 (16.33)    36 (9.18)                                                                       
  Bilateral surgery                      No            191 (97.45)              377 (96.17)                 0.647     .421     0.658   0.236--1.837
  Yes                                    5 (2.55)      15 (3.83)                                                                       
  External CSF drainage                  No            1 (0.51)                 0 (0.00)                    2.003     .333     NA      NA
  Yes                                    195 (99.49)   392 (100.00)                                                                    
  Surgical season                        Spring        31 (15.82)               116 (29.59)                 22.18     \<.001   NA      NA
  Summer                                 58 (29.59)    128 (32.65)                                                                     
  Autumn                                 66 (33.67)    75 (19.13)                                                                      
  Winter                                 41 (20.92)    73 (18.62)                                                                      
  Surgical duration (hr)                 \<4           54 (27.55)               196 (50.00)                 26.98     \<.001   2.630   1.815--3.810
  ≥4                                     142 (72.45)   196 (50.00)                                                                     
  Intraoperative blood loss (ml)         \<400         123 (62.76)              306 (78.06)                 15.51     \<.001   2.112   1.451--3.074
  ≥400                                   73 (37.24)    86 (21.94)                                                                      
  Postoperative oral infection           No            191 (97.45)              390 (99.49)                 4.627     .081     5.105   0.981--26.552
  Yes                                    5 (2.55)      2 (0.51)                                                                        
  Postoperative cerebral hernia          No            190 (96.94)              388 (98.98)                 3.255     .071     3.063   0.854--10.98
  Yes                                    6 (3.06)      4 (1.02)                                                                        
  Postoperative acid inhibitors          No            62 (31.63)               163 (41.58)                 5.475     .019     1.538   1.071--2.209
  Yes                                    134 (68.37)   229 (58.42)                                                                     
  Postoperative ASA score                \<2           15 (7.65)                19 (4.85)                   1.889     .169     0.615   0.305--1.238
  ≥2                                     181 (92.35)   373 (95.15)                                                                     
  Reoperation                            No            175 (89.29)              373 (95.66)                 8.792     .003     2.647   1.362--5.143
  Yes                                    21 (10.71)    17 (4.34)                                                                       
  Postoperative CSF leak                 No            194 (98.98)              392 (100.00)                4.014     .111     NA      NA
  Yes                                    2 (1.02)      0 (0.00)                                                                        
  Postoperative coma                     No            159 (81.12)              345 (88.01)                 5.063     .024     1.708   1.068--2.733
  Yes                                    37 (18.88)    47 (11.99)                                                                      
  Postoperative intensive nursing care   No            183 (93.37)              361 (92.09)                 0.307     .579     0.827   0.423--1.619
  Yes                                    124 (63.27)   203 (51.79)                                                                     
  Postoperative ALB \<40--55 g/L         No            52                       85                          1.718     .190     0.767   0.515--1.141
  Yes                                    144           307                                                                             
  Postoperative ALB \>40--55 g/L         No            189                      389                         4.591     .032     4.802   1.228--18.779
  Yes                                    7             3                                                                               
  Postoperative hsCRP \>0--6 mg/L        No            40                       95                          1.082     .298     1.247   0.822--1.893
  Yes                                    156           297                                                                             
  Postoperative RBC \< normal value      No            92                       184                         0.000     1.000    1.000   0.709--1.410
  Yes                                    104           208                                                                             
  Postoperative RBC \> normal value      No            189                      388                         4.632     .031     3.593   1.039--12.423
  Yes                                    7             4                                                                               
  Postoperative HGB \< normal value      No            95                       190                         0.000     1.000    1.000   0.710--1.409
  Yes                                    101           202                                                                             
  Postoperative HGB \> normal value      No            193                      392                         6.031     .037     NA      NA
  Yes                                    3             0                                                                               

Normal value (postoperative RBC): the total number of normal men and women in the case group and control group, the normal value was 4.3--5.8 × 10^12^ L (men) and 3.8--5.10 × 10^12^ L (women); normal value (postoperative HGB): the total number of normal men and women in the case group and the control group, the normal value was 130--175 g/L (men) and 115--150 g/L (women).

Abbreviations: ALB, albumin; ASA, American Society of Anesthesiologists; CI, confidence interval; CSF, cerebrospinal fluid; HGB, hemoglobin; hsCRP, high‐sensitivity C‐reactive protein; LOS, length of stay; NA, no available value; OR, odds ratio; RBC, red blood cell count.
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Surgery with posterior fossa, surgical season, surgical duration ≥4 hr, intraoperative blood loss ≥400 ml, postoperative oral infection, postoperative cerebral hernia, postoperative using acid inhibitors, reoperation, and postoperative coma were likely correlated with the development of intracranial infection (*p* \< .1). However, preoperative hospital LOS ≥7 days, emergency, bilateral surgery, external CSF drainage, postoperative ASA score ≥2, postoperative CSF leak, and postoperative intensive nursing care were not the potential risk factors related to intracranial infection (*p* \> .1).

Postoperative ALB \> normal value, postoperative RBC \> normal value, and postoperative serum HGB \> normal value were potential risk factors for intracranial infection (*p* \< .1), whereas postoperative ALB \< normal value, postoperative hsCRP \> normal value, postoperative RBC \< normal value, and postoperative serum HGB \< normal value were not the potential risk factors for intracranial infection (*p* \> .1).

3.3. Binary regression analyses for intracranial infection {#brb31658-sec-0019}
----------------------------------------------------------

Male, age ≤45, hypertension, nontrauma surgery, tumor surgery, surgery with posterior fossa, surgical season, surgical duration ≥4 hr, intraoperative blood loss ≥400 ml, postoperative oral infection, postoperative cerebral hernia, postoperative acid inhibitors, reoperation, postoperative coma, and postoperative ALB \> normal value, RBC \> normal value, and serum HGB \> normal value with *p* value lower to .1 were further entered into binary logistic regression model with conditional forward displayed at last step (Table [S2](#brb31658-sup-00002){ref-type="supplementary-material"}). Intracranial infection was selected as dependent variable in binary logistic regression model. After adjustment, the factors with *p* ≥ .05, including surgery with posterior fossa, postoperative cerebral hernia, postoperative acid inhibitors, reoperation, postoperative ALB \> normal value, and serum HGB \> normal value, were excluded. Trauma surgery was retained as independent protective factor for intracranial infection, whereas the other 10 variables were retained as independent risk factors for intracranial infection (*p* \< .05).

Men were 1.775 times (OR = 1.775, 95% CI: 1.185--2.660) likely to be infected with intracranial infection than women. Some factors were related to intracranial infection including age ≤45 (OR = 2.738, 95% CI: 1.737--4.318), hypertension (OR = 1.903, 95% CI: 1.225--2.957), tumor surgery (OR = 2.287, 95% CI: 1.476--3.545), surgical duration ≥4 hr (OR = 1.973, 95% CI: 1.251--3.113), intraoperative blood loss ≥400 ml (OR = 1.871, 95% CI: 1.167--3.001), postoperative oral infection (OR = 6.565, 95% CI: 1.084--39.771), postoperative coma (OR = 4.308, 95% CI: 2.136--8.689), and postoperative RBC \> normal value (OR = 7.838, 95% CI: 1.833--33.507). Season was also an independent risk factor for intracranial infection. In addition, patients who underwent craniotomy in the autumn (*p* \< .05, OR = 2.866, 95% CI: 1.592--5.159) were more susceptible to intracranial infection compared with those who underwent surgery in spring, which served as the baseline, while no relationship existed in other surgical seasons (*p* \> .05). Patients who underwent surgery for trauma could led to corresponding 95.00% (OR = 0.050, 95% CI: 0.017--0.144) reduction of intracranial infection (Table [3](#brb31658-tbl-0003){ref-type="table"}).

###### 

Binary logistic regression analysis for intracranial infections after craniotomy

  Variable                            Unadjusted OR   Unadjusted 95% CI   *B*      *S* ~b~   Wald *χ* ^2^   *p*      OR      95% CI
  ----------------------------------- --------------- ------------------- -------- --------- -------------- -------- ------- ---------------
  Gender                              1.461           1.035--2.062        0.574    0.206     7.752          .005     1.775   1.185--2.660
  Age (years)                         1.709           1.192--2.450        1.007    0.232     18.794         \<.001   2.738   1.737--4.318
  Hypertension                        1.457           1.030--2.060        0.644    0.225     8.191          .004     1.903   1.225--2.957
  Trauma surgery                      0.159           0.072--0.353        −3.005   0.544     30.519         \<.001   0.050   0.017--0.144
  Tumor surgery                       2.748           1.909--3.954        0.827    0.224     13.694         \<.001   2.287   1.476--3.545
  Season (spring)                     NA              NA                  NA       NA        14.004         .003     NA      NA
  Season (summer)                     1.696           1.025--2.505        0.271    0.288     0.883          .347     1.311   0.745--2.307
  Season (autumn)                     3.293           1.965--5.518        1.053    0.300     12.323         \<.001   2.866   1.592--5.159
  Season (winter)                     2.102           1.212--3.645        0.513    0.316     2.632          .105     1.671   0.899--3.105
  Surgical duration ≥4 hr             2.630           1.815--3.810        0.680    0.233     8.533          .003     1.973   1.251--3.113
  Intraoperative blood loss ≥400 ml   2.112           1.451--3.074        0.627    0.241     6.768          .009     1.871   1.167--3.001
  Postoperative oral infection        2.368           1.202--4.666        1.882    0.919     4.192          .041     6.565   1.084--39.771
  Postoperative coma                  2.647           1.362--5.143        1.460    0.358     16.650         \<.001   4.308   2.136--8.689
  Postoperative RBC \> normal value   1.708           1.068--2.733        2.059    0.741     7.716          .005     7.838   1.833--33.507

Abbreviations: CI, confidence interval; OR, odds ratio; RBC, red blood cell count.
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3.4. Distribution of microorganisms isolated from CSF of patients in the case group {#brb31658-sec-0020}
-----------------------------------------------------------------------------------

All 196 patients in the case group with intracranial infection submitted specimens for CSF cultures, and 70 (35.71%) patients had positive results (Table [4](#brb31658-tbl-0004){ref-type="table"}). Gram‐positive pathogens predominated (59 cases, 84.28% of total positive cultures); among them, Coccus were the most common pathogen (57 cases, 81.43% of all Gram‐positives), while only two cases were bacillus. Coccus included nine micrococcus and 49 non‐micrococcus (most commonly *Staphylococcus*, 48 cases). Gram‐negative pathogens (11 cases, 15.71% of positive cultures) were most commonly *Klebsiella pneumoniae* (five cases, 7.14% of all positive cultures) and also included *Acinetobacter baumannii* (two cases), *Pseudomonas* (three cases), and others (one case).

###### 

Types of organisms causing infection

  Organisms                 Number   Percent (%)
  ------------------------- -------- -------------
  Culture‐positive          70       35.714
  Gram‐negative             11       
  Acinetobacter baumannii   2        1.020
  Klebsiella pneumoniae     5        2.551
  Pseudomonas               3        1.531
  Other                     1        0.510
  Gram‐positive             59       
  Bacillus                  2        1.020
  Coccus                    57       
  Micrococcus               8        4.082
  Non‐micrococcus           49       
  Enterobacter              1        0.510
  Staphylococcus            48       
  Epidermidis               19       9.694
  Auricularis               1        0.510
  Saprophyticus             1        0.510
  Aureus                    1        0.510
  Haemolyticus              9        4.592
  Capitis                   4        2.041
  Other                     13       6.633
  Culture‐negative          126      64.286
  Total                     196      100.000

John Wiley & Sons, Ltd

3.5. Antibiotic resistance in pathogens isolated from CSF of patients in the case group {#brb31658-sec-0021}
---------------------------------------------------------------------------------------

All positive isolates were fully resistant to aztreonam, cefazolin, and benzylpenicillin, and susceptible to linezolid and minocycline. A majority of isolates were resistant to cefuroxime (90.91%), penicillin (89.58%), ampicillin (83.33%), ampicillin/sulbactam (81.82%), ceftriaxone (81.82%), erythromycin (74.00%), and biapenem (71.43%). The isolates were highly susceptible to tigecycline (1.85%), vancomycin (2.04%), rifampicin (6.25%), nitrofurantoin (11.86%), amikacin (18.18%), moxifloxacin (20.41%), and gentamicin (26.67%). In addition, the remaining resistant rate varied from 30.61% to 63.64% (Table [5](#brb31658-tbl-0005){ref-type="table"}).

###### 

Antibiotic resistance in pathogens isolated from CSF of patients in the case group

  Antibiotics               Total number   Resistant number   Resistant rate (%)
  ------------------------- -------------- ------------------ --------------------
  Aztreonam                 8              8                  100.00
  Cefazolin                 11             11                 100.00
  Benzylpenicillin          1              1                  100.00
  Cefuroxime                11             10                 90.91
  Penicillin                48             43                 89.58
  Ampicillin                12             10                 83.33
  Ampicillin/sulbactam      11             9                  81.82
  Ceftriaxone               11             9                  81.82
  Erythromycin              50             37                 74.00
  Biapenem                  7              5                  71.43
  Cefotetan                 11             7                  63.64
  Cefepime                  11             7                  63.64
  Piperacillin              11             7                  63.64
  Cefoxitin                 48             30                 62.50
  Clindamycin               49             27                 55.10
  Meropenem                 11             6                  54.55
  Imipenem                  11             6                  54.55
  Ceftazidime               11             5                  45.45
  Tobramycin                11             5                  45.45
  Piperacillin/tazobactam   11             5                  45.45
  Ciprofloxacin             60             26                 43.33
  Levofloxacin              58             25                 43.10
  Cefoperazone/sulbactam    10             4                  40.00
  Polymyxin B               3              1                  33.33
  Tetracycline              49             15                 30.61
  Gentamicin                60             16                 26.67
  Moxifloxacin              49             10                 20.41
  Amikacin                  11             2                  18.18
  Nitrofurantoin            59             7                  11.86
  Rifampicin                48             3                  6.25
  Vancomycin                49             1                  2.04
  Tigecycline               54             1                  1.85
  Linezolid                 49             0                  0.00
  Minocycline               2              0                  0.00
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4. DISCUSSION {#brb31658-sec-0022}
=============

Intracranial infection, one of the most severe postoperative infections after craniotomy, is a difficulty in neurosurgical treatment (Shi et al., [2017](#brb31658-bib-0032){ref-type="ref"}). In the present study, 2,174 patients who underwent craniotomy were enrolled; among them, 196 patients were infected with intracranial infection during hospitalization with a rate of 9.02%. The rate was similar to the previous study, which reported that the incidence of intracranial infection after craniotomy was from 1.4% to 9.5% (Shi et al., [2017](#brb31658-bib-0032){ref-type="ref"}). However, the infection rate was significantly higher than other reports, which might be due to the patient\'s severe condition with a variety of underlying diseases. Although antibiotics and surgical drainage can be used to treat intracranial infection, the BBB provides an obstacle for drug delivery to central nervous system, and CSF only can be drained a little through lumbar puncture. Therefore, it is important to determine the risk factors for intracranial infection after craniotomy. In this study, the results indicated gender, age, CSF leakage, ASA score, surgical duration, and others were the risk factors, which have been reported in previous studies (Fang et al., [2017](#brb31658-bib-0011){ref-type="ref"}; Kourbeti et al., [2007](#brb31658-bib-0023){ref-type="ref"}, [2015](#brb31658-bib-0024){ref-type="ref"}; Lin, Zhao, & Sun, [2015](#brb31658-bib-0026){ref-type="ref"}), while season and postoperative oral infection were firstly taken into account in this study.

Previously, Adaaquah et al have reported that season is related to the variation of arterial blood pressure (Adaaquah et al., [2018](#brb31658-bib-0002){ref-type="ref"}). In this study, *Staphylococci* isolated from infected CSF sample were identified as the major pathogen. *Staphylococci*, as the main infectious bacteria of intracranial infection, could widely distribute on human skin, especially in spring and summer, due to the moister and hotter weather (Kourbeti et al., [2015](#brb31658-bib-0024){ref-type="ref"}; Zhan et al., [2014](#brb31658-bib-0036){ref-type="ref"}). Furthermore, patients who underwent surgery in autumn were more likely to infect with intracranial infection than those who underwent surgery in spring (OR = 2.866, 95% CI: 1.592--5.159). Therefore, in this study, season was firstly explored, and it might be an independent risk factor for intracranial infections, which might recommend that patients after craniotomy should live in a constant temperature and humidity ward. The exact mechanism of seasonal factors for intracranial infection is still further research.

In this study, postoperative oral infection was also identified as an independent risk factor for intracranial infection after craniotomy. Moazzam et al reported bacteria could adversely disseminate from oral infection to intracranial infection (Moazzam et al., [2015](#brb31658-bib-0027){ref-type="ref"}). Previous studies have reported that 1,200 different types of microbes were isolated from the human mouth (Corson, Postlethwaite, & Seymour, [2001](#brb31658-bib-0007){ref-type="ref"}; Dewhirst et al., [2010](#brb31658-bib-0010){ref-type="ref"}). Microorganism in the mouth could enter into the cranial vault via blood, venous drainage, inoculation, or lymphatic drainage (Moazzam et al., [2015](#brb31658-bib-0027){ref-type="ref"}). Furthermore, Andersen and Carpenter et al showed the central nervous system (CNS) infection correlated with oral infection, as 32%--60% of brain abscesses have been shown to be polymicrobial (Andersen & Horton, [1990](#brb31658-bib-0003){ref-type="ref"}; Carpenter, Stapleton, & Holliman, [2007](#brb31658-bib-0005){ref-type="ref"}).

Furthermore, other risk factors for intracranial infections were also explored, such as gender, age, and surgical duration, but there was no consensus on why these factors were risk factors for intracranial infections (Kourbeti et al., [2015](#brb31658-bib-0024){ref-type="ref"}; Lin et al., [2015](#brb31658-bib-0026){ref-type="ref"}). This study showed men were 1.775 times likely to have intracranial infections than women after craniotomy, which might be because men were more likely to smoke and drink alcohol than women. Farrokhi et al have reported smoking could increase the risk of infection during deep brain stimulation surgery (Farrokhi et al., [2019](#brb31658-bib-0012){ref-type="ref"}). More young people choose neurosurgery than the elderly, due to the limitations of income, referral system, and religious beliefs for the elderly (Cassir et al., [2015](#brb31658-bib-0006){ref-type="ref"}; Inoue et al., [2015](#brb31658-bib-0020){ref-type="ref"}). In this study, the ultimately enrolled people were relatively young (48.87 ± 16.21 years), and patients with the age ≤45 years were more susceptible to be infected with intracranial infections (OR = 2.738, 95% CI: 1.737--4.318) than those \>45 years old, which was similar to the report of Zhan et al. ([2014](#brb31658-bib-0036){ref-type="ref"}) but contrary to the report of Fang et al. ([2017](#brb31658-bib-0011){ref-type="ref"}). Some studies have confirmed that longer operation increased the invasion of pathogens into skull and increased the risk of damaging brain tissue (Golebiowski, Drewes, Gulati, Jakola, & Solheim, [2015](#brb31658-bib-0014){ref-type="ref"}; Shi et al., [2017](#brb31658-bib-0032){ref-type="ref"}). Yao and Liu found surgical time was an independent risk factor for intracranial infections after craniotomy through analyzing 94 multiple trauma patients treated with craniotomy (Yao & Liu, [2019](#brb31658-bib-0035){ref-type="ref"}). All the above similarly to this study, surgical duration (≥4 hr) was identified as an independent risk factor for intracranial infections.

In the present study, there were 70 positive cultures among 196 CSF cultures, with a positive rate of 35.71%. Shi et al. reported a higher rate of positive intracranial infection results (42.7%), but patients were all with brain tumors (Shi et al., [2017](#brb31658-bib-0032){ref-type="ref"}). Antibiotic resistance in pathogens isolated from CSF was tested, the finding showed that 69.39% positive cultures were sensitive to tetracycline. Kourbeti et al have reported that one hundred percent of the pathogens isolated from meningitis and ventilator‐associated pneumonia (VAP) was sensitive to tetracycline (Kourbeti et al., [2015](#brb31658-bib-0024){ref-type="ref"}). Different from previous studies, this study found microorganisms isolated from CSF broth were most sensitive to linezolid and minocycline. In addition, the isolates (98.15%) carried a high degree of sensitive to tigecycline. The results could be served as a guide for clinical medications so that clinicians could prescribe drugs more accurately for patients with intracranial infection.

There were two limitations in the present study. The enrolled patients in both case and control groups were all from the Second Hospital of Hebei Medical University, and the samples were not randomly selected to perform craniotomy, which will produce Berkson\'s bias. Thus, patients in multiple hospitals were needed to reduce Berkson\'s bias in the future study. Besides, the sample size of our study was still smaller than the multicenter ones and the confidence interval was narrow. In our future study, we will collect larger sample size to confirm the study.

In conclusion, it was of great significance to explore risk factors for intracranial infection after craniotomy in order to timely prevent it. In this study, surgical season and postoperative oral infection were firstly determined as the new risk factors for intracranial infection. Meanwhile, microorganisms and its antibiotic resistance isolated from intracranial infections were determined. A better understanding of the targeted risk factor, microorganisms, and its antibiotic resistance of intracranial infection after craniotomy could encourage us to adopt more favorable prevention, treatment, and strategies, which contribute to the prognosis of patients.
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